4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-001054
Chief Financial Officer sold 15,000 shares at $77.07 ($1,156,050)
- Chief Financial Officer acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon Stephen Chief Financial Officer | 2024-01-02 | Option exercise 10b5-1 | +15,000 | $13.28 | $199,200 | 28,075 | D: show line 1 in the form |
| Gordon Stephen Chief Financial Officer | 2024-01-02 | Sale 10b5-1 | −15,000 | $77.07 | $1,156,050 | 13,075 | D: show line 2 in the form |
| Open-market sales · 15,000 sh · avg $77.07 · $1,156,050 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon Stephen Chief Financial Officer | 2024-01-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 37,000 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…